BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TG Therapeutics, Inc. 

787 Seventh Avenue
48th Floor
New York  New York  10019  U.S.A.
Phone: 212-554-4484 Fax: 212-554-4531


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
TG Therapeutics, Inc. (MHA) Announces Preclinical Poster Presentations For TGR-1202 At American Association for Cancer Research 2014 4/7/2014 8:59:40 AM    More...
TG Therapeutics, Inc. (MHA) Announces $18.1 Million Underwritten Sale Of Common Stock To A Single Institutional Investor 3/12/2014 8:52:26 AM    More...
TG Therapeutics, Inc. (MHA) To Present At The 26th Annual ROTH Conference 3/10/2014 9:39:49 AM    More...
TG Therapeutics, Inc. (MHA) Announces Fourth Quarter And Year-End 2013 Financial Results And Business Update 3/6/2014 9:17:50 AM    More...
TG Therapeutics, Inc. (MHA) To Present At The 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/10/2014 8:57:42 AM    More...
TG Therapeutics, Inc. (MHA) To Present At The 32nd Annual J.P. Morgan Healthcare Conference 1/14/2014 9:25:26 AM    More...
TG Therapeutics, Inc. (MHA) Announces Presentation Of Encouraging Clinical Activity Of TGR-1202 In An Ongoing Multi-Center Phase I Clinical Study 12/9/2013 9:13:18 AM    More...
TG Therapeutics, Inc. (MHA) Announces Poster Presentations For TGR-1202 At The Upcoming 55th American Society of Hematology Meeting 12/6/2013 9:31:34 AM    More...
TG Therapeutics, Inc. (MHA) Launches Combination Clinical Trial Of TG-1101 And Ibrutinib In Patients With Select B-Cell Malignancies 12/6/2013 9:12:52 AM    More...
TG Therapeutics, Inc. (MHA) To Present At The 2013 Deutsche Bank Biofest Conference 11/26/2013 9:42:03 AM    More...
12345678910...